medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2018, Number 4

<< Back Next >>

Acta Ortop Mex 2018; 32 (4)

Tumor hip prosthesis in fibrous dysplasia of proximal femur. Case report

Corona-Juárez EJ, Catalán-Arizmendi O, Alvarado-Ortega I, García-Cano E, Montiel-Jarquín A

Language: Spanish
References: 11
Page: 225-228
PDF size: 336.94 Kb.


ABSTRACT

Background: fibrous dysplasia is characterized by the formation of fibrous tissue that generates immature malformed trabeculae. Their involvement may be monostotic or poliostotic. Case report: Thirty years old female with fibrous dysplasia of the left hip. At age 15 suffered hip fracture without apparent trauma, she was managed conservatively and significant shortening of the same limb was observed. At 30 years old, is pregnant, it had left hip pain, deformity and shortening is exacerbated. Simple radiography showed «shepherd’s crook deformity», she was treated with bisphosphonates. Computed axial tomography corroborates previous findings. She subsequently underwent subtrochanteric fracture fall with left hip dysplasia site, ground glass image of cystic appearance involving the femoral neck, trochanteric and subtrochanteric area. Tumor prosthesis of the left hip was implanted, four months evolution was favorable. Conclusion: Modular hip prosthesis system, reduces deformity, improves length and reduces pain in patients with resection of fibrous dysplasia of the hip.


REFERENCES

  1. Boyce AM, Chong WH, Yao J, Gafni RI, Kelly MH, Chamberlain CE, et al. Denosumab treatment for fibrous dysplasia. J Bone Miner Res. 2012; 27(7): 1462-70. doi: 10.1002/jbmr.1603.

  2. Riminucci M, Robey PG, Saggio I, Bianco P. Skeletal progenitors and the GNAS gene: fibrous dysplasia of bone read through stem cells. J Mol Endocrinol. 2010; 45(6): 355-64. doi: 10.1677/JME-10-0097.

  3. DiCaprio MR, Enneking WF. Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am. 2005; 87(8): 1848-64. doi: 10.2106/JBJS.D.02942.

  4. Bhattacharyya N, Wiench M, Dumitrescu C, Connolly BM, Bugge TH, Patel HV, et al. Mechanism of FGF23 processing in fibrous dysplasia. J Bone Miner Res. 2012; 27(5): 1132-41.

  5. Cheng J, Wang Y, Yu H, Wang D, Ye J, Jiang H, et al. An epidemiological and clinical analysis of craniomaxillofacial fibrous dysplasia in a Chinese population. Orphanet J Rare Dis. 2012; 7: 80. doi: 10.1186/1750-1172-7-80.

  6. Fitzpatrick KA, Taljanovic MS, Speer DP, Graham AR, Jacobson JA, Barnes GR, et al. Imaging findings of fibrous dysplasia with histopathologic and intraoperative correlation. AJR Am J Roentgenol. 2004; 182(6): 1389-98. doi: 10.2214/ajr.182.6.1821389.

  7. Anderson N, DiBella C, Pianta M, Slavin J, Choong P. Aggressive aneurysmal bone cyst in association with polyostotic fibrous dysplasia: A case report. Int J Surg Case Rep. 2015; 12: 52-6. doi: 10.1016/j.ijscr.2015.05.019.

  8. Chapurlat RD, Gensburger D, Jimenez-Andrade JM, Ghilardi JR, Kelly M, Mantyh P. Pathophysiology and medical treatment of pain in fibrous dysplasia of bone. Orphanet J Rare Dis. 2012; 7 Suppl 1: S3.

  9. Kushare IV, Colo D, Bakhshi H, Dormans JP. Fibrous dysplasia of the proximal femur: surgical management options and outcomes. J Child Orthop. 2014; 8(6): 505-11. doi: 10.1007/s11832-014-0625-9.

  10. Lichtenstein L. Polyostotic fibrous dysplasia. Arch Surg. 1938; 36(5): 874-98.

  11. Lichtenstein L, Jaffe HL. Fibrous dysplasia of bone: a condition affecting one, several or many bones, the graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism or still other extraskeletal abnormalities. Arch Pathol. 1942; 33: 777-816.




2020     |     www.medigraphic.com